Baseline VEGF as a potential predictive biomarker of vandetanib clinical benefit in patients with advanced NSCLC

Detalles Bibliográficos
Main Authors:	Heymach, J, Hanrahan, E, Mann, H, Langmuir, P, Natale, R, Johnson, B, Herbst, R, Ryan, A
Formato:	Journal article
Publicado:	2008

Descripción
Summary:

Títulos similares